BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3599910)

  • 1. Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis.
    Snow AD; Kisilevsky R; Stephens C; Anastassiades T
    Lab Invest; 1987 Jun; 56(6):665-75. PubMed ID: 3599910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
    Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
    Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo analysis of murine serum sulfate metabolism and splenic glycosaminoglycan biosynthesis during acute inflammation and amyloidosis.
    Lyon AW; Anastassiades T; Kisilevsky R
    J Rheumatol; 1993 Jul; 20(7):1108-13. PubMed ID: 8371201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.
    Snow AD; Kisilevsky R
    Lab Invest; 1985 Jul; 53(1):37-44. PubMed ID: 2409350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    Lab Invest; 1985 Mar; 52(3):319-25. PubMed ID: 3974202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of glycosaminoglycan deposition in splenic AA amyloidosis induced in mink.
    Wien TN; Sørby R; Omtvedt LA; Landsverk T; Husby G
    Scand J Immunol; 2004 Dec; 60(6):600-8. PubMed ID: 15584971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis.
    Snow AD; Bramson R; Mar H; Wight TN; Kisilevsky R
    J Histochem Cytochem; 1991 Oct; 39(10):1321-30. PubMed ID: 1940305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence and role of glycosaminoglycans in amyloidosis.
    Linker A; Carney HC
    Lab Invest; 1987 Sep; 57(3):297-305. PubMed ID: 3626519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brefeldin A inhibits experimentally induced AA amyloidosis.
    Stenstad T; Husby G
    J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
    Ailles L; Kisilevsky R; Young ID
    Lab Invest; 1993 Oct; 69(4):443-8. PubMed ID: 8231112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
    Li JP; Galvis ML; Gong F; Zhang X; Zcharia E; Metzger S; Vlodavsky I; Kisilevsky R; Lindahl U
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6473-7. PubMed ID: 15843464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils.
    Snow AD; Willmer J; Kisilevsky R
    Lab Invest; 1987 Dec; 57(6):687-98. PubMed ID: 2447384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of amyloid-enhancing factor.
    Axelrad MA; Kisilevsky R; Willmer J; Chen SJ; Skinner M
    Lab Invest; 1982 Aug; 47(2):139-46. PubMed ID: 7109539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the amyloid SAA 3 gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes.
    Rokita H; Shirahama T; Cohen AS; Meek RL; Benditt EP; Sipe JD
    J Immunol; 1987 Dec; 139(11):3849-53. PubMed ID: 3680951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of proteoglycans and glycosaminoglycans in splenic AA amyloid induced in mink.
    Wien TN; Omtvedt LA; Landsverk T; Husby G
    Scand J Immunol; 2000 Dec; 52(6):576-83. PubMed ID: 11119263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are elevated serum amyloid A levels and amyloid-enhancing factor sufficient to induce inflammation-associated amyloid deposition?
    Kisilevsky R; Tan R; Subrahmanyan L; Snow A
    Appl Pathol; 1984; 2(6):308-15. PubMed ID: 6400464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT; Westermark P
    FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophoresis and detection of nanogram quantities of exogenous and endogenous glycosaminoglycans in biological fluids.
    al-Hakim A; Linhardt RJ
    Appl Theor Electrophor; 1991; 1(6):305-12. PubMed ID: 1718441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study.
    Inoue S; Hultin PG; Szarek WA; Kisilevsky R
    Lab Invest; 1996 Jun; 74(6):1081-90. PubMed ID: 8667612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.